Friday Dec 6
CVS Caremark To Host 2013 Analyst Day For The Investment Community
The company will also provide 2014 earnings guidance during the event. An audio and video webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Caremark website for all interested parties, and will be archived and available for a one-year period.
Thu Dec 05, 2013
CVS Caremark: Enhancing Its Revenue Streams
The Affordable Care Act, which ensures affordable and quality health benefits for American residents, will be fully implemented in 2014.
Wed Dec 04, 2013
Consumer marketing and branding company Authentic Brands Group has acquired the licensing rights to Elvis Presley and Muhammad Ali from Core Media Group, and CVS Caremark has entered into an agreement to buy Apria Healthcare Group's Coram infusion therapy business for approximately $2.1 billion in cash.
CVS Caremark Corp. Price Target Raised to $74.00 at Mizuho
The firm currently has a "buy" rating on the stock. Mizuho's price target would indicate a potential upside of 10.86% from the stock's previous close.
Local Jobs: Pharmacy, Insurance Sales, Teacher, Paraprofessional
CVS Caremark in Mokena is looking for a pharmacy technician trainee/service associate to join the location's pharmacy team.
Tue Dec 03, 2013
CVS Caremark Charitable Trust Awards $25,000 to Nonprofits Nationwide ...
The CVS Caremark Charitable Trust , a private foundation created by CVS Caremark Corporation , today announced the 25 organizations that will receive $1,000 in grants as a part of CVS Caremark's #GivingTuesday initiative , which invited CVS Caremark colleagues to nominate an organization in their community that they volunteer with, to receive a ... (more)
CVS Caremark awards grants to 3 Phoenix nonprofits
The CVS Caremark Charitable Trust has awarded three Phoenix-area nonprofits with $1,000 grants as part of its Giving Tuesday initiative.
CVS whistleblower to get payout for detailing alleged Medicaid scheme
A former CVS Caremark employee will receive $505,680 from the U.S. government for "blowing the whistle" on an alleged scheme that improperly rejected Medicaid-related claims submitted to her one-time employer.
Mon Dec 02, 2013
The Motley Fool
CVS Caremark's Big Thanksgiving Purchase: The Coram Buyout
With a price tag of $2.1 billion, the deal completes a circle started in 1995 by then CVS Corporation when CVS sold its home infusion business for $310 million in an effort to focus on expansion of its retail pharmacy business.
Wrong prescription for drug competition
For a health care market to work you need consumer choice, transparency and a lack of conflicts of interest.
The Motley Fool
Will Rite Aid Continue to Heat Up?
These improvements led the company to reach four consecutive profitable quarters, stable sales, and a slow decline in debt.
Fri Nov 29, 2013
CVS Caremark Corp. Sets New 1-Year High at $67.64
CVS Caremark Corp. 's share price reached a new 52-week high on Friday, American Banking and Market News reports.
CVS Caremark Corp. Receives "Overweight" Rating from Morgan Stanley
's stock had its "overweight" rating reaffirmed by research analysts at Morgan Stanley in a report released on Friday, Analyst Ratings Network reports.
Thu Nov 28, 2013
Big News Network.com
CVS Caremark acquires Coram for $2.1bn
Our eNewspaper network was founded in 2002 to provide stand-alone digital news sites tailored for the most searched-for locations for news.
CVS Caremark - Little Appeal Despite A Nice Strategic Addition
Investors in C VS Caremark applaud the company's move to acquire Coram, boosting the long term strategic appeal of the company.
Wed Nov 27, 2013
Rite Aid: Back On Track?
In October, Rite Aid announced its same store sales, or comps, result for the four weeks ended on October 26, 2013.
ModernGraham Valuation Of CVS Caremark
Here is a look at how CVS Caremark fares in ModernGraham's opinion, based on an updated and modernized version of Benjamin Graham's requirements of defensive and enterprising investors from The Intelligent Investor: Earnings Growth earnings per share has increased by at least 1/3 over the last 10 years using 3 year averages at beginning and end of ... (more)
The Motley Fool
CVS Caremark to Acquire Apria Healthcare Unit for $2.1 Billion
CVS did not disclose how the deal would be funded. CVS ended its fiscal 2013 third quarter on Sept.
The Beaumont Enterprise
CVS Caremark to buy Coram for $2.1 billion
Drugstore chain operator CVS Caremark Corp. said Wednesday that it has agreed to buy the drug infusion business Coram LLC, a unit of Apria Healthcare Group Inc. , for $2.1 billion.
CVS Caremark to buy Apria's infusion business for $2.1 billion
CVS, which operates a drugstore chain and a pharmacy benefits management unit, said Coram would add $1.4 billion to revenues in the first year after the deal closes and 3 to 5 cents per share to CVS's adjusted earnings per share in 2015.